(Q37238204)
Statements
1 reference
Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial (English)
1 reference
R Loch Macdonald
1 reference
Neal F Kassell
1 reference
Daniel Ruefenacht
1 reference
Peter Schmiedek
1 reference
Stephan Weidauer
1 reference
Aline Frey
1 reference
Sebastien Roux
1 reference
Alberto Pasqualin
1 reference
CONSCIOUS-1 Investigators
1 reference
7 August 2008
1 reference
1 reference
39
1 reference
11
1 reference
3015-3021
1 reference
Identifiers
1 reference
1 reference